Table 1

Comparison of PSMB SNP allelic frequencies in pretreatment (n = 47) and posttreatment (n = 29) samples from MM patients with population frequency data (European, whenever available) from the National Center for Biotechnology Information (NCBI) SNP database

GeneSNP IDAmino acidsAllelesNCBI frequencyObserved frequencyFDR P
Pretreatment samples 
    PSMB1 rs12717 P11A C/G 0.61/0.39 0.58/0.42 .813 
    PSMB5 rs11543947 R24C C/T NA* 0.95/0.05 NA 
    PSMB6 rs3169950 A21A G/A 0.57/0.43 0.67/0.33 .386 
rs11552523 T56T T/C 0.99/0.02 0.98/0.02 > .999 
rs2304974 P107A C/G 0.91/0.09 0.94/0.06 .746 
rs2304975 S115S C/T 0.64/0.36 0.77/0.23 .081 
rs7468 Y177Y C/T 0.91/0.09 0.93/0.07 .740 
    PSMB8 rs17220206 S70T T/A 0.97/0.03 1.00/0.00 .573 
    PSMB9 rs35100697 G9E G/A 0.97/0.03 1.00/0.00 > .999 
rs241419 V32I G/A 0.99/0.01 0.98/0.02 .777 
rs17587 R60H G/A 0.70/0.30 0.77/0.23 .635 
rs20547 A161A A/G 0.99/0.01 0.94/0.06 .081 
rs17213861 R173C C/T 0.98/0.02 1.00/0.00 .740 
    PSMB10 rs20549 L107L T/C 0.83/0.17 0.72/0.28 .168 
rs14178 G151G T/C 0.95/0.05 0.87/0.13 .057 
Posttreatment samples 
    PSMB1 rs12717 P11A C/G 0.61/0.39 0.63/0.38 > .999 
    PSMB5 rs11543947 R24C C/T NA* 0.83/0.17 NA 
    PSMB6 rs3169950 A21A G/A 0.57/0.43 0.41/0.59 .499 
rs11552523 T56T T/C 0.99/0.02 0.97/0.03 .701 
rs2304974 P107A C/G 0.91/0.09 0.97/0.03 .701 
rs2304975 S115S C/T 0.64/0.36 0.97/0.03 < .001 
rs7468 Y177Y C/T 0.91/0.09 0.96/0.04 .701 
    PSMB8 rs17220206 S70T T/A 0.97/0.03 1.00/0.00 .701 
    PSMB9 rs35100697 G9E G/A 0.97/0.03 1.00/0.00 > .999 
rs241419 V32I G/A 0.99/0.01 0.98/0.02 .701 
rs17587 R60H G/A 0.70/0.30 0.79/0.21 .701 
rs20547 A161A A/G 0.99/0.01 0.88/0.12 .021 
rs17213861 R173C C/T 0.98/0.02 1.00/0.00 > .999 
    PSMB10 rs20549 L107L T/C 0.83/0.17 0.72/0.28 .499 
rs14178 G151G T/C 0.95/0.05 0.91/0.09 .612 
GeneSNP IDAmino acidsAllelesNCBI frequencyObserved frequencyFDR P
Pretreatment samples 
    PSMB1 rs12717 P11A C/G 0.61/0.39 0.58/0.42 .813 
    PSMB5 rs11543947 R24C C/T NA* 0.95/0.05 NA 
    PSMB6 rs3169950 A21A G/A 0.57/0.43 0.67/0.33 .386 
rs11552523 T56T T/C 0.99/0.02 0.98/0.02 > .999 
rs2304974 P107A C/G 0.91/0.09 0.94/0.06 .746 
rs2304975 S115S C/T 0.64/0.36 0.77/0.23 .081 
rs7468 Y177Y C/T 0.91/0.09 0.93/0.07 .740 
    PSMB8 rs17220206 S70T T/A 0.97/0.03 1.00/0.00 .573 
    PSMB9 rs35100697 G9E G/A 0.97/0.03 1.00/0.00 > .999 
rs241419 V32I G/A 0.99/0.01 0.98/0.02 .777 
rs17587 R60H G/A 0.70/0.30 0.77/0.23 .635 
rs20547 A161A A/G 0.99/0.01 0.94/0.06 .081 
rs17213861 R173C C/T 0.98/0.02 1.00/0.00 .740 
    PSMB10 rs20549 L107L T/C 0.83/0.17 0.72/0.28 .168 
rs14178 G151G T/C 0.95/0.05 0.87/0.13 .057 
Posttreatment samples 
    PSMB1 rs12717 P11A C/G 0.61/0.39 0.63/0.38 > .999 
    PSMB5 rs11543947 R24C C/T NA* 0.83/0.17 NA 
    PSMB6 rs3169950 A21A G/A 0.57/0.43 0.41/0.59 .499 
rs11552523 T56T T/C 0.99/0.02 0.97/0.03 .701 
rs2304974 P107A C/G 0.91/0.09 0.97/0.03 .701 
rs2304975 S115S C/T 0.64/0.36 0.97/0.03 < .001 
rs7468 Y177Y C/T 0.91/0.09 0.96/0.04 .701 
    PSMB8 rs17220206 S70T T/A 0.97/0.03 1.00/0.00 .701 
    PSMB9 rs35100697 G9E G/A 0.97/0.03 1.00/0.00 > .999 
rs241419 V32I G/A 0.99/0.01 0.98/0.02 .701 
rs17587 R60H G/A 0.70/0.30 0.79/0.21 .701 
rs20547 A161A A/G 0.99/0.01 0.88/0.12 .021 
rs17213861 R173C C/T 0.98/0.02 1.00/0.00 > .999 
    PSMB10 rs20549 L107L T/C 0.83/0.17 0.72/0.28 .499 
rs14178 G151G T/C 0.95/0.05 0.91/0.09 .612 

All frequencies totaled 1.00, although some appear not to due to being rounded to the nearest hundredth unit.

FDR indicates false discovery rate; and NA, not applicable.

*

NCBI frequency data are inconclusive. Bold font indicates statistical significance (FDR P < .05).

NCBI European frequency data unavailable (listed frequency is weighted average from available NCBI population data).

NCBI European frequency data unavailable (different major/minor allele depending on population).

or Create an Account

Close Modal
Close Modal